In this presentation, Peter O’Callaghan discusses how Lonza's optimized transient expression workflow combines the benefits of transient protein expression and the construction of stable pools. Our novel ‘hybrid’ process, part of our GS Discovery® offering, boosts transient expression titers for early phase material generation.

You may also be interested in:
Expression Technologies
Bispecific Antibody
Difficult to Express Proteins
Monoclonal Antibody
GS Gene Expression System®
GS piggyBac® Transposon System
GS Xceed® Gene Expression System
Mammalian Expression Technologies
GS Discovery®
Author(s):
Peter O'Callaghan, Ph.D.
Head of Expression System Sciences
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.
Latest briefing from the Knowledge Center
Webinar (on-demand)
Commercial Tech Transfers in OSD Manufacturing
This webinar explores the critical aspects of manufacturing commercial tech transfers for the...
Two men working in the lab micro pipetting.
R&D Blog post
In-use stability and compatibility of Biologics – How to safely administer an effective medicinal...
Lonza_Bend_InhalationLab.010
White paper
The Role of Excipients in Inhaled Biologics
The field of inhaled biologics is rapidly expanding, with both dry and liquid formulations of...
CDMO Notes Blog post
Accelerated Tox Offerings: A Recipe for Streamlining IND Applications
Webinar (on-demand)
Lonza Biologics Drug Product OPCU Capacity Update
Explore Lonza Biologics' end-to-end Drug Product capabilities along the full life cycle, seamlessly...
Lonza Bend Solid Form Services
Webinar (on-demand)
De-Risking Early Phase Micronization with Integrated Solid Form Selection
Achieving the right particle size for respiratory drug delivery is crucial, and jet milling is a...
Microdosing graphic
Article
Accelerating Drug Development with Precision Powder Micro-Dosing
Webinar (on-demand)
Producing Engineered Extracellular Vesicles with a Platform Approach
In this webinar, we'll discuss materials and methods to enable the expression of biomolecules on...
Visp HPAPI Kg Suite
R&D Blog post
Delivering a consistently excellent service with advanced process technologies
As a chemical engineer, it’s perhaps unsurprising that I find it immensely satisfying to use...
CDMO Notes Blog post
A Faster Path to the Clinic: Accelerating Biologics Development with Integrated Solutions
How Lonza’s team are helping to revolutionise the path to Biologics INDs, with an accelerated...
Podcast
A View On mRNA Encapsulation (S04 E03)
In this episode, we are joined by three experts—Christoph Hein (Fraunhofer IPK), Bern-hard Bobusch...
PBPK Scientists on tablet
Webinar (on-demand)
Accelerating Clinical Development: Modern Tools in Process Chemistry
This webinar explores how Lonza leverages High-Throughput Experimentation (HTE) and a model-based...